Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Charles Thomas currently holds 0 shares of Krystal Biotech, Inc. (KRYS), valued at approximately $0. This represents their equity stake as EVP, General Counsel.
Based on SEC Form 4 filings, John Charles Thomas has been a net seller of KRYS stock. They have purchased $0 and sold $193.9K worth of shares.
John Charles Thomas's most recent insider trade was on May 26, 2026, when they sold 642 shares at $302.03 per share.
John Charles Thomas serves as EVP, General Counsel at Krystal Biotech, Inc. (KRYS). They have executed 1 insider transactions totaling $193.9K over their tenure at the company.
John Charles Thomas holds the position of EVP, General Counsel at Krystal Biotech, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
John Charles Thomas has shown a selling trading pattern, with $0 in total purchases and $193.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John Charles Thomas was on May 26, 2026, when they sold $193.9K worth of KRYS shares. This transaction involved 642 shares at $302.03 per share.
John Charles Thomas currently owns 0 shares of Krystal Biotech, Inc. (KRYS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Charles Thomas's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Charles Thomas has 1 Form 4 filings on record as an insider at Krystal Biotech, Inc..
Set alerts for John Charles Thomas and 40,000+ other insiders.